122 related articles for article (PubMed ID: 5431259)
1. [Indication for neoplasm chemotherapy and administration of antineoplastic agents].
Hiraki K; Kimura I
Naika; 1970 Jun; 25(6):1163-9. PubMed ID: 5431259
[No Abstract] [Full Text] [Related]
2. Re: Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy?
Block K; Koch A; Mead M; Newman RA; Gyllenhaal C
J Natl Cancer Inst; 2009 Jan; 101(2):124-5; author reply 125-6. PubMed ID: 19141775
[No Abstract] [Full Text] [Related]
3. [Potentiation of the effects of antineoplastic agents].
Wad T; Oara H
Gan No Rinsho; 1971 Mar; 17(3):173-7. PubMed ID: 4926146
[No Abstract] [Full Text] [Related]
4. Growth kinetics of minimal tumour masses: implications for rational chemotherapy.
Pileri A; Boccadoro M; Mandelli F; Amadori S
Haematologica; 1981 Oct; 66(5):545-53. PubMed ID: 6796464
[No Abstract] [Full Text] [Related]
5. [Mechanisms of action of drug therapy of cancer].
García G
Gac Med Mex; 1972 Feb; 103(2):129-45. PubMed ID: 5022797
[No Abstract] [Full Text] [Related]
6. The use of intravesical chemotherapy and possibilities for improving its efficacy.
Sylvester RJ
Eur Urol; 2006 Aug; 50(2):233. PubMed ID: 18219714
[No Abstract] [Full Text] [Related]
7. [Polychemotherapy of tumors and therapeutic synergism].
Stukov AN
Vopr Onkol; 1979; 25(9):91-6. PubMed ID: 483726
[No Abstract] [Full Text] [Related]
8. [Oxaliplatin: perspectives and future developments].
Marty M; Cottu PH; Lerebours F; Bedairia N; Hocini H; Espié M
Bull Cancer; 2001 Aug; 88 Spec No():S5-8. PubMed ID: 11567907
[No Abstract] [Full Text] [Related]
9. [Rationalization of adjuvant chemotherapy by induction chemotherapy].
Hoerni B; Chauvergne J
Bull Cancer; 1984; 71(4):297-300. PubMed ID: 6498345
[TBL] [Abstract][Full Text] [Related]
10. Rationale for the selection of chemotherapeutic agents.
Hryniuk WM; Bertino JR
Adv Intern Med; 1969; 15():267-97. PubMed ID: 4908621
[No Abstract] [Full Text] [Related]
11. Are targeted therapies really targeted?
Schilsky RL
Clin Adv Hematol Oncol; 2003 Dec; 1(12):722-3. PubMed ID: 16258475
[No Abstract] [Full Text] [Related]
12. Only an overall 15% net benefit emerges in favour of adjuvant intravesical chemotherapy when compared to transurethral resection alone for the prevention of recurrences of superficial bladder tumors.
Colombo R
Eur Urol; 2006 Aug; 50(2):233-4. PubMed ID: 18219715
[No Abstract] [Full Text] [Related]
13. [Combined drug therapy and its significance].
Ota K
Nihon Rinsho; 1969 Jun; 27(6):1571-7. PubMed ID: 5816826
[No Abstract] [Full Text] [Related]
14. Efficacy of oral anticancer agents for colorectal cancer.
Sakamoto J; Oba K; Matsui T; Kobayashi M
Dis Colon Rectum; 2006 Oct; 49(10 Suppl):S82-91. PubMed ID: 17106820
[No Abstract] [Full Text] [Related]
15. [Trial in potentiation of antineoplastic effects].
Yunoki K
Nihon Rinsho; 1975 May; 33(5):1886-91. PubMed ID: 1171283
[No Abstract] [Full Text] [Related]
16. Chemotherapy drug administration: a beginning survey of chemotherapy as a workload index.
Campbell S; Hallgren L; Kamitomo V; Catedral C
Cancer Nurs; 1984 Jun; 7(3):213-20. PubMed ID: 6562925
[No Abstract] [Full Text] [Related]
17. Issues in chemotherapy administration.
Spross J
Oncol Nurs Forum; 1982; 9(1):50-4. PubMed ID: 6916370
[No Abstract] [Full Text] [Related]
18. Current concepts in chemotherapy administration.
Semin Oncol Nurs; 1987 May; 3(2):83-158. PubMed ID: 3646728
[No Abstract] [Full Text] [Related]
19. [60 cases of advanced cancer treated by an association of ambulatory cytostatics during 1 to 4 years. Collaborational hospital consultation and doctors in charge of the cases].
Israel L; Depierre A
Therapeutique; 1970 Apr; 46(4):415-7. PubMed ID: 4987709
[No Abstract] [Full Text] [Related]
20. [Multiple drug therapy of malignant tumor using fibroblast-suppresive agents as the basis].
Kimura I; Moritani Y; Yamana M; Onoshi T; Nishizaki Y
Nihon Rinsho; 1970 Sep; 28(9):2318-21. PubMed ID: 5466668
[No Abstract] [Full Text] [Related]
[Next] [New Search]
